How and when to search for microsatellite instability in colorectal cancer in 2008?

被引:4
作者
Paraf, Francois [1 ,2 ]
机构
[1] Ctr Hosp Univ Dupuytren, Serv Anat Pathol, F-87042 Limoges, France
[2] Fac Med Limoges, F-87025 Limoges, France
关键词
colorectal cancer; HNPCC syndrome; microsatellite instability; immunohistochemistry;
D O I
10.1016/S0242-6498(07)71415-3
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Hereditary non polyposis colorectal cancer or Lynch syndrome is due to germline mutation of one the DNA mismatch repair genes. This mutation is associated with an unstable phenotype in tumor DNA characterized by new microsatellite alleles that ore absent in matching normal DNA. Besides the Bethesda reference panel, a new panel of 5 mononucleotide microsatellites (BAT25, BAT26, NR21, NR24, NR27) has been proposed, which is more sensitive and faster to use in a multiplex PCR assay. In tumor cells, immunohistochemistry detects the loss of expression of either MLHI, MSH2, MSH6 or PMS2 protein, corresponding to the mutated gene. Immunohistochemistry guides germline analysis, except for MLHI extinction which may correspond to either MLHI germline mutation or methylation of MLH1 promoter resulting in inactivation. The latter is mostly due to aging and is often associated to the V600E BRAF gene mutation in tumor DNA. Combination of these 3 somatic analyses should reduce indications of germ-line mutation analysis in Lynch syndrome.
引用
收藏
页码:433 / 438
页数:6
相关论文
共 25 条
[1]   Use of microsatellite instability and immunohistochemistry testing for the identification of individuals at risk for Lynch syndrome [J].
Baudhuin, LM ;
Burgart, LJ ;
Leontovich, O ;
Thibodeau, SN .
FAMILIAL CANCER, 2005, 4 (03) :255-265
[2]   Value of microsatellite instability typing in detecting hereditary non-polyposis colorectal cancer -: A prospective multicentric study by the Association Aquitaine Gastro [J].
Bécouarn, Y ;
Rullier, A ;
Gorry, P ;
Smith, D ;
Richard-Molard, B ;
Echinard, E ;
Texereau, P ;
Beyssac, R ;
Legoux, JL ;
Lamouliatte, H ;
Frebourg, T ;
Olschwang, S ;
Gilbert, B ;
Venat, L ;
Picot, V ;
Paraf, F ;
Longy, M .
GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2005, 29 (6-7) :667-675
[3]  
Boland CR, 1998, CANCER RES, V58, P5248
[4]   Multipopulation analysis of polymorphisms in five mononucleotide repeats used to determine the microsatellite instability status of human tumors [J].
Buhard, O ;
Cattaneo, F ;
Wong, YF ;
Yim, SF ;
Friedman, E ;
Flejou, JF ;
Duval, A ;
Hamelin, R .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (02) :241-251
[5]   Mutations of the BRAF gene in human cancer [J].
Davies, H ;
Bignell, GR ;
Cox, C ;
Stephens, P ;
Edkins, S ;
Clegg, S ;
Teague, J ;
Woffendin, H ;
Garnett, MJ ;
Bottomley, W ;
Davis, N ;
Dicks, N ;
Ewing, R ;
Floyd, Y ;
Gray, K ;
Hall, S ;
Hawes, R ;
Hughes, J ;
Kosmidou, V ;
Menzies, A ;
Mould, C ;
Parker, A ;
Stevens, C ;
Watt, S ;
Hooper, S ;
Wilson, R ;
Jayatilake, H ;
Gusterson, BA ;
Cooper, C ;
Shipley, J ;
Hargrave, D ;
Pritchard-Jones, K ;
Maitland, N ;
Chenevix-Trench, G ;
Riggins, GJ ;
Bigner, DD ;
Palmieri, G ;
Cossu, A ;
Flanagan, A ;
Nicholson, A ;
Ho, JWC ;
Leung, SY ;
Yuen, ST ;
Weber, BL ;
Siegler, HF ;
Darrow, TL ;
Paterson, H ;
Marais, R ;
Marshall, CJ ;
Wooster, R .
NATURE, 2002, 417 (6892) :949-954
[6]   Microsatellite instability, immunohistochemistry, and additional PMS2 staining in suspected hereditary nonpolyposis colorectal cancer [J].
de Jong, AE ;
van Puijenbroek, M ;
Hendriks, Y ;
Tops, C ;
Wijnen, J ;
Ausems, MGEM ;
Meijers-Heijboer, H ;
Wagner, A ;
van Os, TAM ;
Bröcker-Vriends, AHJT ;
Vasen, HFA ;
Morreau, H .
CLINICAL CANCER RESEARCH, 2004, 10 (03) :972-980
[7]   BRAF mutation is frequently present in sporadic colorectal cancer with methylated hMLH1, but not in hereditary nonpolyposis colorectal cancer [J].
Deng, GR ;
Bell, I ;
Crawley, S ;
Gum, J ;
Terdiman, JP ;
Allen, BA ;
Truta, B ;
Sleisenger, MH ;
Kim, YS .
CLINICAL CANCER RESEARCH, 2004, 10 (01) :191-195
[8]   RRAF-V600E is not involved in the colorectal tumorigenesis of HNPCC in patients with functional MLH1 and MSH2 genes [J].
Domingo, E ;
Niessen, RC ;
Oliveira, C ;
Alhopuro, P ;
Moutinho, C ;
Espín, E ;
Armengol, M ;
Sijmons, RH ;
Kleibeuker, JH ;
Seruca, R ;
Aaltonen, LA ;
Imai, K ;
Yamamoto, H ;
Schwartz, S ;
Hofstra, RMW .
ONCOGENE, 2005, 24 (24) :3995-3998
[9]   BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing [J].
Domingo, E ;
Laiho, P ;
Ollikainen, M ;
Pinto, M ;
Wang, L ;
French, AJ ;
Westra, J ;
Frebourg, T ;
Espín, E ;
Armengol, M ;
Hamelin, R ;
Yamamoto, H ;
Hofstra, RMW ;
Seruca, R ;
Lindblom, A ;
Peltomäki, P ;
Thibodeau, SN ;
Aaltonen, LA ;
Schwartz, S .
JOURNAL OF MEDICAL GENETICS, 2004, 41 (09) :664-668
[10]   Activated BRAF targets proximal colon tumors with mismatch repair deficiency and MLH1 inactivation [J].
Domingo, E ;
Espín, E ;
Armengol, M ;
Oliveira, C ;
Pinto, M ;
Duval, A ;
Brennetot, C ;
Seruca, R ;
Hamelin, R ;
Yamamoto, H ;
Schwartz, S .
GENES CHROMOSOMES & CANCER, 2004, 39 (02) :138-142